Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Jagsonpal Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	10,952	14,422	7,313	7,592	8,214	2,085
Market Cap Growth	-33.54%	97.22%	-3.68%	-7.58%	293.91%	353.56%
Enterprise Value	9,448	13,741	6,290	7,175	7,748	1,574
Last Close Price	163.73	215.01	108.21	112.14	121.33	29.88
PE Ratio	26.99	26.05	32.55	28.41	43.57	12.23
PS Ratio	3.89	5.37	3.50	3.21	3.78	1.11
PB Ratio	4.33	6.01	3.90	4.78	6.19	1.71
P/TBV Ratio	6.40	9.35	3.90	4.78	6.19	1.71
P/FCF Ratio	-	26.24	20.94	16.39	140.06	7.51
P/OCF Ratio	-	26.08	20.80	16.27	118.81	7.39
EV/Sales Ratio	3.36	5.11	3.01	3.03	3.56	0.84
EV/EBITDA Ratio	16.02	27.69	28.44	20.67	30.37	7.92
EV/EBIT Ratio	20.45	32.00	29.11	21.18	32.30	8.38
EV/FCF Ratio	-	25.01	18.01	15.49	132.10	5.67
Debt / Equity Ratio	0.04	0.04	0.05	0.04	-	0.06
Debt / EBITDA Ratio	0.15	0.18	0.38	0.17	-	0.34
Debt / FCF Ratio	-	0.17	0.26	0.13	-	0.25
Asset Turnover	-	1.09	1.01	1.32	1.33	1.20
Inventory Turnover	-	6.42	4.52	3.68	3.02	2.75
Quick Ratio	-	5.48	8.31	4.92	2.32	1.89
Current Ratio	-	6.22	10.29	5.97	4.04	2.98
Return on Equity (ROE)	-	25.91%	12.97%	18.32%	14.81%	14.64%
Return on Assets (ROA)	-	10.84%	6.55%	11.79%	9.13%	7.51%
Return on Invested Capital (ROIC)	33.87%	40.30%	32.94%	36.65%	22.30%	20.33%
Return on Capital Employed (ROCE)	-	17.00%	10.90%	20.20%	17.50%	15.20%
Earnings Yield	3.73%	3.84%	3.07%	3.52%	2.30%	8.18%
FCF Yield	-	3.81%	4.78%	6.10%	0.71%	13.31%
Dividend Yield	1.51%	1.16%	1.85%	1.78%	1.32%	1.34%
Payout Ratio	-	23.90%	58.31%	-	55.58%	15.36%
Buyback Yield / Dilution	-0.36%	-1.56%	-1.23%	-	-	-
Total Shareholder Return	1.15%	-0.39%	0.62%	1.78%	1.32%	1.34%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.